Skip to content


  • Correction
  • Open Access

Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy

  • 1,
  • 1,
  • 1, 2,
  • 1,
  • 1, 2,
  • 1,
  • 1,
  • 1, 3,
  • 1, 4,
  • 4,
  • 5,
  • 6,
  • 1,
  • 4 and
  • 1Email author
Journal of Hematology & Oncology201811:90

Received: 25 June 2018

Accepted: 25 June 2018

Published: 3 July 2018

The original article was published in Journal of Hematology & Oncology 2018 11:58


The original article [1] contains a spelling error in the authorship; the authors would like to note the correct spelling of the second author, Jiajia Xi.



Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, China
Raman Fellow (UGC), Department of Biochemistry, University of Allahabad, Allahabad, India
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Cancer Research Institute, Central South University, Changsha, China
Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, USA


  1. Huang Q, et al. miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy. J Hematol Oncol. 2018;11:58.View ArticlePubMedPubMed CentralGoogle Scholar


© The Author(s). 2018